Company / Tangible Book Value per Share
Biogen Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$81.20
FY2025
5-year range
$29.48 / $81.20
FY2021-FY2025
Trend
+14.2%
vs FY2024
Sector context
#6 of 211
Health Care
What the data says
Among 211 Health Care companies, Biogen is in the top 3% for tangible book value per share. Tangible Book Value per Share has increased for 5 consecutive years, from $25.04 in FY2020 to $81.20 in FY2025.
Based on SEC 10-K filings.
81.20 in FY2025 with a 5-year CAGR of +26.5%. Top quartile in the Health Care sector.
Improved from $58.37 to $81.20 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +17.4%
- 5-Year CAGR
- +26.5%
- 10-Year CAGR
- -
Sector benchmark
-31.6% below sector average
Key checks
Key Insights
- Biogen's tangible book value per share has grown for 5 consecutive years.
- In FY2025, tangible book value per share increased 14.2% year-over-year.
- Ranks #6 out of 211 companies in the Health Care sector.
- Lowest tangible book value per share in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $81.20 | +14.2% |
| FY2024 | $71.09 | +21.8% |
| FY2023 | $58.37 | +16.3% |
| FY2022 | $50.19 | +70.3% |
| FY2021 | $29.48 | +17.7% |
| FY2020 | $25.04 | -30.2% |
| FY2019 | $35.86 | +5.6% |
| FY2018 | $33.97 | -8.1% |
| FY2017 | $36.96 | -4.6% |
| FY2016 | $38.75 | +35.5% |
As of FY2025 · SEC 10-K · Updated Mar 3, 2026